Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Cataract Surgery – Market size and forecast 2017-2022
• Glaucoma surgery – Market size and forecast 2017-2022
• Diabetic eye surgery – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Availability of advanced technology
• Shift toward ASCs for eye care
• Availability of advanced IOLs implants

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Carl Zeiss Meditec
• Novartis
• Valeant Pharmaceuticals
• TOPCON
• Johnson & Johnson
• List of abbreviations

[List of Exhibits]
Exhibit 01: Parent market
Exhibit 02: Global ophthalmology devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Application – Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: Cataract Surgery – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Cataract Surgery – Year over year growth 2018-2022 (%)
Exhibit 22: Glaucoma surgery – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Glaucoma surgery – Year over year growth 2018-2022 (%)
Exhibit 24: Diabetic eye surgery – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Diabetic eye surgery – Year over year growth 2018-2022 (%)
Exhibit 26: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Others – Year over year growth 2018-2022 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Global – Market share by geography 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas – Year over year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year over year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC – Year over year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Vendor overview
Exhibit 48: Carl Zeiss Meditec – Business segments
Exhibit 49: Carl Zeiss Meditec – Organizational developments
Exhibit 50: Carl Zeiss Meditec – Geographic focus
Exhibit 51: Carl Zeiss Meditec – Segment focus
Exhibit 52: Carl Zeiss Meditec – Key offerings
Exhibit 53: Carl Zeiss Meditec – Key customers
Exhibit 54: Vendor overview
Exhibit 55: Novartis – Business segments
Exhibit 56: Novartis – Organizational developments
Exhibit 57: Novartis – Geographic focus
Exhibit 58: Novartis – Segment focus
Exhibit 59: Novartis: Key offerings
Exhibit 60: Novartis: Key customers
Exhibit 61: Vendor overview
Exhibit 62: Valeant Pharmaceuticals – Business segments
Exhibit 63: Valeant Pharmaceuticals – Organizational developments
Exhibit 64: Valeant Pharmaceuticals – Geographic focus
Exhibit 65: Valeant Pharmaceuticals – Segment focus
Exhibit 66: Valeant Pharmaceuticals – Key offerings
Exhibit 67: Valeant Pharmaceuticals – Key customers
Exhibit 68: Vendor overview
Exhibit 69: TOPCON – Business segments
Exhibit 70: TOPCON – Organizational developments
Exhibit 71: TOPCON – Geographic focus
Exhibit 72: TOPCON – Segment focus
Exhibit 73: TOPCON – Key offerings
Exhibit 74: TOPCON – Key customers
Exhibit 75: Vendor overview
Exhibit 76: Johnson & Johnson – Business segments
Exhibit 77: Johnson & Johnson – Organizational developments
Exhibit 78: Johnson & Johnson – Geographic focus
Exhibit 79: Johnson & Johnson – Segment focus
Exhibit 80: Johnson & Johnson: Key offerings
Exhibit 81: Johnson & Johnson: Key customers